Breast Cancer (MSK, Clinical Cancer Res 2020)

Summary

Breast Cancer (MSK, Clinical Cancer Res 2020) is a study catalogued by cBioPortal DataHub under the cancer-type code brca. EvidenceHelix groups it with breast studies.

Study description

Whole-exome and MSK-IMPACT sequencing of 60 tumor/normal matched samples.

Text as published in the source's study metadata.

Citation & PubMed

Fresia et al. Clinical Cancer Res 2020

Linked PubMed records: PMID 32220886

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

brca_pareja_msk_2020

Short name

BRCA (MSK, PARJERA 2020)

Source cancer-type code

brca

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Fresia et al. Clinical Cancer Res 2020

• PubMed record 32220886 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Breast Cancer (MSK, NPJ Breast Cancer 2019)

  Targeted Sequencing of buparlisib + letrozole and alpelisib + letrozole-treated metastatic ER+ unmatched breast tumors.

  BreastMSK studiesSource code brcaPubMed 1

• Juvenile Papillomatosis and Breast Cancer (MSK,J Pathol. 2015)

  Whole-exome sequencing analysis of juvenile papillomatosis and coexisting breast carcinoma.

  BreastMSK studiesSource code brcaPubMed 1

• MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)

  MSK-IMPACT targeted sequencing of 145 breast tumors with matched normal samples.

  BreastMSK studiesSource code brcaPubMed 1

• Breast Cancer (HTAN, 2022)

  An omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical meta…

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)

  Targeted sequencing of 2509 primary breast tumors with 548 matched normals.

  BreastOther published and consortium studiesSource code brcaPubMed 3

• Breast Cancer (SMC 2018)

  Whole-exome sequencing of 187 primary tumors from a Korean breast cancer cohort (SMC).

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Cancer Xenografts (British Columbia, Nature 2015)

  Whole genome/targeted sequencing to evaluate the clonal dynamics in 116 breast cancer patient xenografts.

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Invasive Carcinoma (British Columbia, Nature 2012)

  Whole genome/exome sequencing analysis of 65 breast cancer samples

  BreastOther published and consortium studiesSource code brcaPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.